+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Assisted Reproductive Technology Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

  • PDF Icon

    Report

  • 400 Pages
  • May 2026
  • Region: Global
  • Expert Market Research
  • ID: 5895161
The global assisted reproductive technology market was valued at USD 25.07 Billion in 2025. It is poised to grow at a CAGR of 6.50% during the forecast period of 2026-2035, and reach USD 47.06 Billion by 2035. The market growth is driven by the rising global infertility, delayed parenthood, and increasing awareness of fertility preservation, driving demand for IVF and assisted reproductive technologies, expanding fertility clinic services and accelerating growth in the ART market.

Key Market Trends and Insights

  • Europe dominated the market in the historical period, accounting for the largest revenue share of over 36%.
  • By outlook, the IVF segment captured the maximum share, representing approximately 91% of the global revenue in the historical period.
  • By end-use, the fertility clinics and other facilities segment led the market, holding the largest share of more than 79% in the historical period.

Market Size and Forecast

  • Market Size (2025): USD 25.07 Billion
  • Projected Market Size (2035): USD 47.06 Billion
  • CAGR (2026-2035): 6.50%

Assisted Reproductive Technology Market Overview

The global market is expanding due to rising infertility rates, growing awareness of fertility preservation, and advancements in IVF and ICSI procedures. Increasing adoption of embryo transfer, blastocyst culture, and egg freezing enhances treatment success. Investments in fertility clinics, regulatory support, and improved access to reproductive healthcare are further driving market growth worldwide. The market reached a value of approximately USD 25.07 Billion in 2025.

Assisted Reproductive Technology Market Growth Drivers

Rising Infertility Prevalence Fueling the Market Demand

Infertility affects roughly one in six people of reproductive age worldwide, creating significant demand for fertility care services. According to the World Health Organization, millions face barriers to conception and require interventions, including advanced treatments such as IVF. This high global burden of infertility is prompting greater adoption of assisted reproductive technologies, expanding access to fertility clinics, supporting regulatory initiatives, and driving sustained growth in ART services through the forecast period.

Assisted Reproductive Technology Market Trends

Key trends shaping the assisted reproductive technology market include rising infertility, IVF adoption, fertility preservation, and government-supported accessibility initiatives worldwide.

Increasing Government Initiatives to Boost the Market Expansion

Rising infertility rates and declining birth rates are driving the adoption of assisted reproductive technologies globally. For instance, in March 2026, China announced expanded public insurance subsidies for IVF treatments, increasing accessibility to fertility services nationwide. This policy encourages more couples to pursue embryo transfer and fertility preservation procedures, supporting growth in egg freezing and broader assisted reproductive technology adoption. Such government initiatives are expected to strengthen market expansion in the forecast period.

Assisted Reproductive Technology Market Segmentation

Market Breakup by Type

  • In-Vitro Fertilization (IVF)
  • Fresh Donor
  • Frozen Donor
  • Fresh non-Donor
  • Frozen non-Donor
  • Artificial Insemination
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intravaginal Insemination
  • Intratubal Insemination

Market Breakup by Product

  • Instrument
  • Accessory and Disposable
  • Reagent and Media

Market Breakup by Age

  • Women Younger Than Age 35
  • Women Older Than Age 35

Market Breakup by Application

  • Frozen Embryo Replacement (FER)
  • Surrogacy
  • Ovulation Induction
  • Others

Market Breakup by End User

  • Fertility Clinics and Other Facilities
  • Hospitals and Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Assisted Reproductive Technology Market Share

In-Vitro Fertilization (IVF) to Dominate the Market Segment by Outlook

The IVF segment captured the largest share of the market, representing approximately 91% of revenue in the historical period. Increasing adoption of advanced fertility procedures is enhancing success rates and patient satisfaction. Clinics are integrating new techniques, expanding access and improving outcomes. Rising awareness of reproductive healthcare and technological advancements continues to support growth in this segment across multiple regions.

Assisted Reproductive Technology Market Analysis by Region

Europe dominated the market in the historical period, accounting for over 36% of global revenue. The region benefits from strong healthcare infrastructure, high patient awareness, and advanced treatment facilities. Widespread adoption of fertility services supports market expansion. Investments in healthcare, regulatory support, and improved treatment accessibility further reinforce Europe’s position, making it a leading region for the assisted reproductive technology market.

Leading Players in the Assisted Reproductive Technology Market

The key features of the market report comprise patent analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:

Cosmos Biomedical Ltd.

Founded in 2005 and headquartered in the United Kingdom, Cosmos Biomedical Ltd. supplies diagnostic products, laboratory equipment, and CPD education to healthcare and fertility research institutions. Their offerings support assisted reproductive procedures, enabling precise laboratory analysis and quality control. The company provides tools for blastocyst culture, fertility preservation, and preimplantation genetic testing, helping clinics optimize outcomes for patients pursuing assisted reproductive technology worldwide.

European Sperm Bank

The European Sperm Bank specializes in reproductive solutions, offering personalized donor matching, high-quality sperm and oocyte cryopreservation services, and guidance for intrauterine insemination and IVF cycles. The organization also supports surrogacy programs and fertility preservation. Their patient-centric approach ensures safe, ethical, and high-standard care for families seeking sperm donation, egg freezing, and assisted reproductive technology, maintaining comprehensive support from consultation to treatment completion.

Bloom IVF Centre

Bloom IVF Centre, based in India, provides advanced assisted reproductive technology treatments. The clinic specializes in IVF, ovarian stimulation, blastocyst culture, and preimplantation genetic testing. Services include ICSI, embryo transfer, egg freezing, and fertility preservation. With multiple centers nationwide, Bloom IVF addresses both male and female fertility needs. Their expertise and comprehensive approach make them a trusted provider in India’s growing ART market, supporting patients through personalized care.

California Cryobank

Headquartered in Los Angeles, California Cryobank offers specialized assisted reproductive technology services including intrauterine insemination, IVF, and fertility preservation programs. They provide high-quality sperm for ICSI, GIFT, ZIFT, and blastocyst culture procedures. Additional services include oocyte cryopreservation, embryo transfer, and surrogacy support. By maintaining clinical standards and patient-centered solutions, the organization meets diverse reproductive needs, supporting fertility clinics and individuals across the United States.

Other key players in the market are Anecova, CooperSurgical, Merck KGaA, Ferring B.V., FUJIFILM Irvine Scientific, Genea Pty Ltd., Nidacon International AB, Celmatix Inc., Microm U.K. Ltd., Cryolab Ltd., Vitrolife AB and Nikon corporation.

Key Questions Answered in the Assisted Reproductive Technology Market Report

  • What was the assisted reproductive technology market value in 2025?
  • What is the assisted reproductive technology market forecast outlook for 2026-2035?
  • What major factors aid the demand for assisted reproductive technology market?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market’s major drivers, opportunities, and restraints?
  • What are the major assisted reproductive technology market trends?
  • Which type is expected to dominate the market segment?
  • Which product is projected to lead the market segment?
  • Which age is likely to lead the market segment?
  • Which application is likely to lead the market segment?
  • Which end user is likely to dominate the market segment?
  • Who are the key players in the assisted reproductive technology market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Assisted Reproductive Technology Market Overview
3.1 Global Assisted Reproductive Technology Market Historical Value (2019-2025)
3.2 Global Assisted Reproductive Technology Market Forecast Value (2026-2035)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Assisted Reproductive Technology Market Landscape*
5.1 Global Assisted Reproductive Technology Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Assisted Reproductive Technology Market: Product Landscape
5.2.1 Analysis by Type
6 Global Assisted Reproductive Technology Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Assisted Reproductive Technology Market Segmentation (219-2035)
7.1 Global Assisted Reproductive Technology Market (2019-2035) by Type
7.1.1 Market Overview
7.1.2 In-Vitro Fertilization (IVF)
7.1.2.1 Fresh Donor
7.1.2.2 Frozen Donor
7.1.2.3 Fresh Non-Donor
7.1.2.4 Frozen Non-Donor
7.1.3 Artificial Insemination
7.1.3.1 Intrauterine Insemination
7.1.3.2 Intracervical Insemination
7.1.3.3 Intravaginal Insemination
7.1.3.4 Intratubal Insemination
7.2 Global Assisted Reproductive Technology Market (2019-2035) by Product
7.2.1 Market Overview
7.2.2 Instrument
7.2.3 Accessory & Disposable
7.2.4 Reagent & Media
7.3 Global Assisted Reproductive Technology Market (2019-2035) by Age
7.3.1 Market Overview
7.3.2 Women Younger Than Age 35
7.3.3 Women Older Than Age 35
7.4 Global Assisted Reproductive Technology Market (2019-2035) by Application
7.4.1 Market Overview
7.4.2 Frozen Embryo Replacement (FER)
7.4.3 Surrogacy
7.4.4 Ovulation Induction
7.4.5 Others
7.5 Global Assisted Reproductive Technology Market (2019-2035) by End User
7.5.1 Market Overview
7.5.2 Fertility Clinics & Other Facilities
7.5.3 Hospitals & Others
7.6 Global Assisted Reproductive Technology Market (2019-2035) by Region
7.6.1 Market Overview
7.6.2 North America
7.6.3 Europe
7.6.4 Asia Pacific
7.6.5 Latin America
7.6.6 Middle East and Africa
8 North America Assisted Reproductive Technology Market (219-2035)
8.1 North America Assisted Reproductive Technology Market (2019-2035) by Type
8.1.1 Market Overview
8.1.2 In-Vitro Fertilization (IVF)
8.1.2.1 Fresh Donor
8.1.2.2 Frozen Donor
8.1.2.3 Fresh Non-Donor
8.1.2.4 Frozen Non-Donor
8.1.3 Artificial Insemination
8.1.3.1 Intrauterine Insemination
8.1.3.2 Intracervical Insemination
8.1.3.3 Intravaginal Insemination
8.1.3.4 Intratubal Insemination
8.2 North America Assisted Reproductive Technology Market (2019-2035) by Product
8.2.1 Market Overview
8.2.2 Instrument
8.2.3 Accessory & Disposable
8.2.4 Reagent & Media
8.3 North America Assisted Reproductive Technology Market (2019-2035) by Age
8.3.1 Market Overview
8.3.2 Women Younger Than Age 35
8.3.3 Women Older Than Age 35
8.4 North America Assisted Reproductive Technology Market (2019-2035) by Application
8.4.1 Market Overview
8.4.2 Frozen Embryo Replacement (FER)
8.4.3 Surrogacy
8.4.4 Ovulation Induction
8.4.5 Others
8.5 North America Assisted Reproductive Technology Market (2019-2035) by End User
8.5.1 Market Overview
8.5.2 Fertility Clinics & Other Facilities
8.5.3 Hospitals & Others
8.6 North America Assisted Reproductive Technology Market (2019-2035) by Country
8.6.1 United States of America
8.6.1.1 United States of America Assisted Reproductive Technology Market (2019-2035) by Product
8.6.2 Canada
8.6.2.1 Canada Assisted Reproductive Technology Market (2019-2035) by Product
9 Europe Assisted Reproductive Technology Market (219-2035)
9.1 Europe Assisted Reproductive Technology Market (2019-2035) by Type
9.1.1 Market Overview
9.1.2 In-Vitro Fertilization (IVF)
9.1.2.1 Fresh Donor
9.1.2.2 Frozen Donor
9.1.2.3 Fresh Non-Donor
9.1.2.4 Frozen Non-Donor
9.1.3 Artificial Insemination
9.1.3.1 Intrauterine Insemination
9.1.3.2 Intracervical Insemination
9.1.3.3 Intravaginal Insemination
9.1.3.4 Intratubal Insemination
9.2 Europe Assisted Reproductive Technology Market (2019-2035) by Product
9.2.1 Market Overview
9.2.2 Instrument
9.2.3 Accessory & Disposable
9.2.4 Reagent & Media
9.3 Europe Assisted Reproductive Technology Market (2019-2035) by Age
9.3.1 Market Overview
9.3.2 Women Younger Than Age 35
9.3.3 Women Older Than Age 35
9.4 Europe Assisted Reproductive Technology Market (2019-2035) by Application
9.4.1 Market Overview
9.4.2 Frozen Embryo Replacement (FER)
9.4.3 Surrogacy
9.4.4 Ovulation Induction
9.4.5 Others
9.5 Europe Assisted Reproductive Technology Market (2019-2035) by End User
9.5.1 Market Overview
9.5.2 Fertility Clinics & Other Facilities
9.5.3 Hospitals & Others
9.6 Europe Assisted Reproductive Technology Market (2019-2035) by Country
9.6.1 United Kingdom
9.6.1.1 United Kingdom Assisted Reproductive Technology Market (2019-2035) by Product
9.6.2 Germany
9.6.2.1 Germany Assisted Reproductive Technology Market (2019-2035) by Product
9.6.3 France
9.6.3.1 France Assisted Reproductive Technology Market (2019-2035) by Product
9.6.4 Italy
9.6.4.1 Italy Assisted Reproductive Technology Market (2019-2035) by Product
9.6.5 Others
10 Asia Pacific Assisted Reproductive Technology Market (219-2035)
10.1 Asia Pacific Assisted Reproductive Technology Market (2019-2035) by Type
10.1.1 Market Overview
10.1.2 In-Vitro Fertilization (IVF)
10.1.2.1 Fresh Donor
10.1.2.2 Frozen Donor
10.1.2.3 Fresh Non-Donor
10.1.2.4 Frozen Non-Donor
10.1.3 Artificial Insemination
10.1.3.1 Intrauterine Insemination
10.1.3.2 Intracervical Insemination
10.1.3.3 Intravaginal Insemination
10.1.3.4 Intratubal Insemination
10.2 Asia Pacific Assisted Reproductive Technology Market (2019-2035) by Product
10.2.1 Market Overview
10.2.2 Instrument
10.2.3 Accessory & Disposable
10.2.4 Reagent & Media
10.3 Asia Pacific Assisted Reproductive Technology Market (2019-2035) by Age
10.3.1 Market Overview
10.3.2 Women Younger Than Age 35
10.3.3 Women Older Than Age 35
10.4 Asia Pacific Assisted Reproductive Technology Market (2019-2035) by Application
10.4.1 Market Overview
10.4.2 Frozen Embryo Replacement (FER)
10.4.3 Surrogacy
10.4.4 Ovulation Induction
10.4.5 Others
10.5 Asia Pacific Assisted Reproductive Technology Market (2019-2035) by End User
10.5.1 Market Overview
10.5.2 Fertility Clinics & Other Facilities
10.5.3 Hospitals & Others
10.6 Asia Pacific Assisted Reproductive Technology Market (2019-2035) by Country
10.6.1 China
10.6.1.1 China Assisted Reproductive Technology Market (2019-2035) by Product
10.6.2 Japan
10.6.2.1 Japan Assisted Reproductive Technology Market (2019-2035) by Product
10.6.3 India
10.6.3.1 India Assisted Reproductive Technology Market (2019-2035) by Product
10.6.4 ASEAN
10.6.4.1 ASEAN Assisted Reproductive Technology Market (2019-2035) by Product
10.6.5 Australia
10.6.5.1 Australia Assisted Reproductive Technology Market (2019-2035) by Product
10.6.6 Others
11 Latin America Assisted Reproductive Technology Market (219-2035)
11.1 Latin America Assisted Reproductive Technology Market (2019-2035) by Type
11.1.1 Market Overview
11.1.2 In-Vitro Fertilization (IVF)
11.1.2.1 Fresh Donor
11.1.2.2 Frozen Donor
11.1.2.3 Fresh Non-Donor
11.1.2.4 Frozen Non-Donor
11.1.3 Artificial Insemination
11.1.3.1 Intrauterine Insemination
11.1.3.2 Intracervical Insemination
11.1.3.3 Intravaginal Insemination
11.1.3.4 Intratubal Insemination
11.2 Latin America Assisted Reproductive Technology Market (2019-2035) by Product
11.2.1 Market Overview
11.2.2 Instrument
11.2.3 Accessory & Disposable
11.2.4 Reagent & Media
11.3 Latin America Assisted Reproductive Technology Market (2019-2035) by Age
11.3.1 Market Overview
11.3.2 Women Younger Than Age 35
11.3.3 Women Older Than Age 35
11.4 Latin America Assisted Reproductive Technology Market (2019-2035) by Application
11.4.1 Market Overview
11.4.2 Frozen Embryo Replacement (FER)
11.4.3 Surrogacy
11.4.4 Ovulation Induction
11.4.5 Others
11.5 Latin America Assisted Reproductive Technology Market (2019-2035) by End User
11.5.1 Market Overview
11.5.2 Fertility Clinics & Other Facilities
11.5.3 Hospitals & Others
11.6 Latin America Assisted Reproductive Technology Market (2019-2035) by Country
11.6.1 Brazil
11.6.1.1 Brazil Assisted Reproductive Technology Market (2019-2035) by Product
11.6.2 Argentina
11.6.2.1 Argentina Assisted Reproductive Technology Market (2019-2035) by Product
11.6.3 Mexico
11.6.3.1 Mexico Assisted Reproductive Technology Market (2019-2035) by Product
11.6.4 Others
12 Middle East and Africa Assisted Reproductive Technology Market (219-2035)
12.1 Middle East and Africa Assisted Reproductive Technology Market (2019-2035) by Type
12.1.1 Market Overview
12.1.2 In-Vitro Fertilization (IVF)
12.1.2.1 Fresh Donor
12.1.2.2 Frozen Donor
12.1.2.3 Fresh Non-Donor
12.1.2.4 Frozen Non-Donor
12.1.3 Artificial Insemination
12.1.3.1 Intrauterine Insemination
12.1.3.2 Intracervical Insemination
12.1.3.3 Intravaginal Insemination
12.1.3.4 Intratubal Insemination
12.2 Middle East and Africa Assisted Reproductive Technology Market (2019-2035) by Product
12.2.1 Market Overview
12.2.2 Instrument
12.2.3 Accessory & Disposable
12.2.4 Reagent & Media
12.3 Middle East and Africa Assisted Reproductive Technology Market (2019-2035) by Age
12.3.1 Market Overview
12.3.2 Women Younger Than Age 35
12.3.3 Women Older Than Age 35
12.4 Middle East and Africa Assisted Reproductive Technology Market (2019-2035) by Application
12.4.1 Market Overview
12.4.2 Frozen Embryo Replacement (FER)
12.4.3 Surrogacy
12.4.4 Ovulation Induction
12.4.5 Others
12.5 Middle East and Africa Assisted Reproductive Technology Market (2019-2035) by End User
12.5.1 Market Overview
12.5.2 Fertility Clinics & Other Facilities
12.5.3 Hospitals & Others
12.6 Middle East and Africa Assisted Reproductive Technology Market (2019-2035) by Country
12.6.1 Saudi Arabia
12.6.1.1 Saudi Arabia Assisted Reproductive Technology Market (2019-2035) by Product
12.6.2 United Arab Emirates
12.6.2.1 United Arab Emirates Assisted Reproductive Technology Market (2019-2035) by Product
12.6.3 Nigeria
12.6.3.1 Nigeria Assisted Reproductive Technology Market (2019-2035) by Product
12.6.4 South Africa
12.6.4.1 South Africa Assisted Reproductive Technology Market (2019-2035) by Product
12.6.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Initiatives
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 Microm U.K. Ltd.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Development
17.2.5 Certifications
17.3 CooperSurgical, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Development
17.3.5 Certifications
17.4 FUJIFILM Irvine Scientific
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Development
17.4.5 Certifications
17.5 Cyprus IVF Centre
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Development
17.5.5 Certifications
17.6 Vita Altera IVF Center
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Development
17.6.5 Certifications
17.7 Cryolab Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Development
17.7.5 Certifications
17.8 Vitrolife AB
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Development
17.8.5 Certifications
17.9 European Sperm Bank
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Development
17.9.5 Certifications
17.10 Bloom IVF Centre
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Company News and Development
17.10.5 Certifications
17.11 Merck KGaA
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Company News and Development
17.11.5 Certifications
18 Global Assisted Reproductive Technology Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Cosmos Biomedical Ltd.
  • European Sperm Bank
  • Bloom IVF Centre
  • California Cryobank